MIM
MRTX

Macroview Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Macroview Investment Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-67
Closed -$3.94K – 719
2023
Q4 		$3.94K Sell
67
-208
-76% -$11.7K ﹤0.01% 423
2023
Q3 		$12K Buy
+275
New +$9.82K 0.02% 211

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macroview Investment Management's MRTX Position: Q1 2024 in Review

Macroview Investment Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 67 shares — an estimated $3.94K sold.

Macroview Investment Management first reported a position in MRTX in Q3 2023 and held it in 2 quarters. The position peaked at $12K in Q3 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Macroview Investment Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Macroview Investment Management sold 67 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.94K.
  • Macroview Investment Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Macroview Investment Management's Mirati Therapeutics, Inc. Common Stock position peaked at $12K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Macroview Investment Management's 13F filing for Q1 2024, filed 30 Apr 2024.